Viroclinics Biosciences to set up Chinese JV

ROTTERDAM, THE NETHERLANDS – To provide better clinical laboratory services to our Chinese and other Asian customers, Viroclinics Biosciences is in negotiations with financial and strategic partners in China. Additionally Viroclinics will be a silver sponsor and exhibitor at the World Vaccine Congress Asia, which will take place from June 17th to 20th at the Grand Copthorne Waterfront Hotel in Singapore.

World Vaccine Congress Asia 2013, Asia’s largest vaccine event, brings together all the major vaccine stakeholders, including pharmaceutical and biotech firms, NGOs, research institutes, regulators and CDCs to discuss the latest industry trends, business strategies and scientific developments in the global and Asian vaccine markets. Besides that, this Terrapin organized event is co-located with the Asia largest Antibody Congress and commercially focused orphan drug event.

“We hope to meet a lot of existing and new relations at the World Vaccine Congress Asia 2013,” said Bob van Gemen, CEO of Viroclinics Biosciences, “and discuss the possibilities for partnering and delivering our high quality laboratory service in clinical studies.”